SIH Cancer Institute is a clinical research site located in Carterville, Illinois, United States 62918.
Crixeo Health Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.
SIH Cancer Institute has participated in 201 clinical trials with 152 currently active.
Therapeutic areas: Ovarian Granulosa Cell Tumor, Ovarian Gynandroblastoma, Ovarian Sertoli-Leydig Cell Tumor.
Sponsors: GOG Foundation, National Cancer Institute (NCI), ECOG-ACRIN Cancer Research Group.
Trust Score: 89/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
SIH Cancer Institute has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
SIH Cancer Institute has 201 clinical trials on record, with 152 currently active. Their work covers Ovarian Granulosa Cell Tumor, Ovarian Gynandroblastoma, Ovarian Sertoli-Leydig Cell Tumor.
SIH Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.